Literature DB >> 9372954

p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner.

L J Ko1, S Y Shieh, X Chen, L Jayaraman, K Tamai, Y Taya, C Prives, Z Q Pan.   

Abstract

The tumor suppressor protein p53 acts as a transcriptional activator that can mediate cellular responses to DNA damage by inducing apoptosis and cell cycle arrest. p53 is a nuclear phosphoprotein, and phosphorylation has been proposed to be a means by which the activity of p53 is regulated. The cyclin-dependent kinase (CDK)-activating kinase (CAK) was originally identified as a cellular kinase required for the activation of a CDK-cyclin complex, and CAK is comprised of three subunits: CDK7, cyclin H, and p36MAT1. CAK is part of the transcription factor IIH multiprotein complex, which is required for RNA polymerase II transcription and nucleotide excision repair. Because of the similarities between p53 and CAK in their involvement in the cell cycle, transcription, and repair, we investigated whether p53 could act as a substrate for phosphorylation by CAK. While CDK7-cyclin H is sufficient for phosphorylation of CDK2, we show that p36MAT1 is required for efficient phosphorylation of p53 by CDK7-cyclin H, suggesting that p36MAT1 can act as a substrate specificity-determining factor for CDK7-cyclin H. We have mapped a major site of phosphorylation by CAK to Ser-33 of p53 and have demonstrated as well that p53 is phosphorylated at this site in vivo. Both wild-type and tumor-derived mutant p53 proteins are efficiently phosphorylated by CAK. Furthermore, we show that p36 and p53 can interact both in vitro and in vivo. These studies reveal a potential mechanism for coupling the regulation of p53 with DNA repair and the basal transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372954      PMCID: PMC232579          DOI: 10.1128/MCB.17.12.7220

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

Review 1.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Identification of redox/repair protein Ref-1 as a potent activator of p53.

Authors:  L Jayaraman; K G Murthy; C Zhu; T Curran; S Xanthoudakis; C Prives
Journal:  Genes Dev       Date:  1997-03-01       Impact factor: 11.361

3.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

4.  The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor.

Authors:  R Roy; J P Adamczewski; T Seroz; W Vermeulen; J P Tassan; L Schaeffer; E A Nigg; J H Hoeijmakers; J M Egly
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

5.  The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.

Authors:  M Kitagawa; H Higashi; H K Jung; I Suzuki-Takahashi; M Ikeda; K Tamai; J Kato; K Segawa; E Yoshida; S Nishimura; Y Taya
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

6.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.

Authors:  C J Thut; J L Chen; R Klemm; R Tjian
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

7.  Expression and activity of p40MO15, the catalytic subunit of cdk-activating kinase, during Xenopus oogenesis and embryogenesis.

Authors:  A J Brown; T Jones; J Shuttleworth
Journal:  Mol Biol Cell       Date:  1994-08       Impact factor: 4.138

8.  Allosteric activation of latent p53 tetramers.

Authors:  T R Hupp; D P Lane
Journal:  Curr Biol       Date:  1994-10-01       Impact factor: 10.834

9.  Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK.

Authors:  W J Feaver; J Q Svejstrup; N L Henry; R D Kornberg
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

10.  Cell cycle regulation of the p34cdc2/p33cdk2-activating kinase p40MO15.

Authors:  R Y Poon; K Yamashita; M Howell; M A Ershler; A Belyavsky; T Hunt
Journal:  J Cell Sci       Date:  1994-10       Impact factor: 5.285

View more
  43 in total

1.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Authors:  N H Chehab; A Malikzay; E S Stavridi; T D Halazonetis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

3.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

4.  Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription.

Authors:  M E Martin; A J Berk
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 5.  Phosphorylation in transcription: the CTD and more.

Authors:  T Riedl; J M Egly
Journal:  Gene Expr       Date:  2000

6.  A cyclin-dependent kinase-activating kinase regulates differentiation of root initial cells in Arabidopsis.

Authors:  M Umeda; C Umeda-Hara; H Uchimiya
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 7.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

8.  The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation.

Authors:  Gan Wang; Lynn Chuang; Xiaohong Zhang; Stephanie Colton; Alan Dombkowski; John Reiners; Amy Diakiw; Xiaoxin Susan Xu
Journal:  Nucleic Acids Res       Date:  2004-04-23       Impact factor: 16.971

9.  MEKK1/JNK signaling stabilizes and activates p53.

Authors:  S Y Fuchs; V Adler; M R Pincus; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities.

Authors:  P Kaldis; A A Russo; H S Chou; N P Pavletich; M J Solomon
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.